• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-24-1-5p 通过靶向 SHOX2 抑制肾透明细胞癌的恶性表型。

MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2.

机构信息

Department of Oncology, Lishui People's Hospital, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, 323000, China.

Department of Urology Surgery, Lishui People's Hospital, The Sixth Affiliated Hospital of Wenzhou Medical University, No. 15 Dazhong Street, Liandu District, Lishui, 323000, China.

出版信息

Biochem Genet. 2023 Oct;61(5):2004-2019. doi: 10.1007/s10528-023-10353-5. Epub 2023 Mar 14.

DOI:10.1007/s10528-023-10353-5
PMID:36917325
Abstract

MiRNAs are essential epigenetic modulators that can regulate protein expression. According to the principle of base complementary pairing, miRNA is partially or completely complementary to the 3'-UTR region of its target gene, by which it inhibits the translation of the targeted gene. This study investigated the role of miR-24-1-5p in clear cell renal cell carcinoma (ccRCC). Data in TCGA-KIRC denoted that miR-24-1-5p was under-expressed in ccRCC. Bioinformatics analysis predicted that its target gene was SHOX2, which was significantly expressed in cancer tissues. Dual luciferase assay verified the targeting relationship between miR-24-1-5p and SHOX2. Cell function experiments demonstrated that overexpression of miR-24-1-5p significantly inhibited SHOX2 level and the malignant phenotypes of ccRCC cells. The above results illustrated that miR-24-1-5p/SHOX2 axis was critical for the oncogenesis and development of ccRCC, which might be helpful for us to understand the mechanism and novel therapeutic methods of ccRCC.

摘要

miRNAs 是重要的表观遗传调节剂,可以调节蛋白质的表达。根据碱基互补配对原则,miRNA 与靶基因的 3'-UTR 区域部分或完全互补,从而抑制靶基因的翻译。本研究探讨了 miR-24-1-5p 在透明细胞肾细胞癌(ccRCC)中的作用。TCGA-KIRC 中的数据表明,miR-24-1-5p 在 ccRCC 中表达下调。生物信息学分析预测其靶基因是 SHOX2,在癌组织中显著表达。双荧光素酶报告基因实验验证了 miR-24-1-5p 与 SHOX2 之间的靶向关系。细胞功能实验表明,miR-24-1-5p 的过表达显著抑制了 SHOX2 水平和 ccRCC 细胞的恶性表型。上述结果表明,miR-24-1-5p/SHOX2 轴在 ccRCC 的发生发展中起着关键作用,这可能有助于我们理解 ccRCC 的发病机制和新的治疗方法。

相似文献

1
MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2.miR-24-1-5p 通过靶向 SHOX2 抑制肾透明细胞癌的恶性表型。
Biochem Genet. 2023 Oct;61(5):2004-2019. doi: 10.1007/s10528-023-10353-5. Epub 2023 Mar 14.
2
MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.miR-212-5p 通过靶向 TBX15 抑制肾透明细胞癌细胞的恶性行为。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10699-10707. doi: 10.26355/eurrev_201912_19770.
3
[MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1].[微小RNA-744-5p通过靶向细胞周期蛋白D1抑制肾透明细胞癌细胞的增殖、侵袭和迁移]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):712-717. doi: 10.12122/j.issn.1673-4254.2022.05.12.
4
miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.miR-155-5p 通过靶向 PEG3 促进透明细胞肾细胞癌的细胞增殖和迁移。
Urol Int. 2021;105(9-10):906-915. doi: 10.1159/000514416. Epub 2021 Jun 30.
5
MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.miR-182-5p 通过抑制 UBE2T 抑制肾透明细胞癌的肿瘤发生。
Hum Cell. 2022 Mar;35(2):542-556. doi: 10.1007/s13577-021-00661-6. Epub 2022 Feb 7.
6
serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma.在透明细胞肾细胞癌中作为一种新型生物标志物,通过吸附miR-204-5p和上调RAB22A来促进肿瘤进展。
Ann Med. 2021 Dec;53(1):2153-2164. doi: 10.1080/07853890.2021.2001563.
7
The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2.假定的肿瘤抑制因子微小RNA-30a-5p通过抑制ZEB2来调节肾透明细胞癌的侵袭性。
Cell Death Dis. 2017 Jun 1;8(6):e2859. doi: 10.1038/cddis.2017.252.
8
MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.微小RNA-30a-5p通过调节GRP78表达抑制肾细胞癌的生长。
Cell Physiol Biochem. 2017;43(6):2405-2419. doi: 10.1159/000484394. Epub 2017 Oct 27.
9
MicroRNA-204-5p Hampers the Malignant Progression of Clear Cell Renal Cell Carcinoma through GXYLT2 Downregulation.miR-204-5p 通过下调 GXYLT2 抑制肾透明细胞癌的恶性进展。
Kidney Blood Press Res. 2022;47(11):654-663. doi: 10.1159/000526540. Epub 2022 Sep 5.
10
Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.阻断长链非编码 RNA MIR155HG/miR-155-5p/-3p 抑制肾透明细胞癌的增殖、侵袭和迁移。
Pathol Res Pract. 2020 Feb;216(2):152803. doi: 10.1016/j.prp.2019.152803. Epub 2019 Dec 24.

引用本文的文献

1
N6-methyladenosine-modified long non-coding RNA promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression.N6-甲基腺苷修饰的长链非编码RNA通过上调SHOX2表达促进肝细胞癌的干性和索拉非尼耐药性。
World J Gastroenterol. 2024 Dec 28;30(48):5174-5190. doi: 10.3748/wjg.v30.i48.5174.
2
Orthopedic manifestations of Li-Fraumeni syndrome: Prevention and treatment of a polymorphic spectrum of malignancies.李-弗劳梅尼综合征的骨科表现:多形性恶性肿瘤谱的预防与治疗
World J Clin Cases. 2024 Sep 16;12(26):5839-5844. doi: 10.12998/wjcc.v12.i26.5839.
3
Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment.

本文引用的文献

1
Analysis of the Prognostic Value and Gene Expression Mechanism of in Lung Adenocarcinoma.肺腺癌中[具体内容]的预后价值及基因表达机制分析。 你提供的原文中“Analysis of the Prognostic Value and Gene Expression Mechanism of in Lung Adenocarcinoma.”有缺失部分,我按照完整的翻译逻辑进行了补充,请根据实际情况修改。
Front Mol Biosci. 2021 Jun 28;8:688274. doi: 10.3389/fmolb.2021.688274. eCollection 2021.
2
MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2.微小RNA-935通过靶向铁调节元件结合蛋白2促进肾透明细胞癌的迁移和侵袭。
Cancer Manag Res. 2019 Dec 30;11:10891-10900. doi: 10.2147/CMAR.S232380. eCollection 2019.
3
揭示二硫键自噬在肾透明细胞癌中的隐藏作用:一个用于个性化治疗的预后标志物。
Apoptosis. 2024 Jun;29(5-6):693-708. doi: 10.1007/s10495-023-01933-2. Epub 2024 Jan 31.
Circ-AKT3 inhibits clear cell renal cell carcinoma metastasis via altering miR-296-3p/E-cadherin signals.
环状 RNA-AKT3 通过改变 miR-296-3p/E-钙黏蛋白信号抑制透明细胞肾细胞癌转移。
Mol Cancer. 2019 Nov 1;18(1):151. doi: 10.1186/s12943-019-1072-5.
4
Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer.miR-153表达增加预示前列腺癌患者预后不良。
Medicine (Baltimore). 2019 Sep;98(36):e16705. doi: 10.1097/MD.0000000000016705.
5
MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.miR-223-3p 通过靶向 SHOX2 抑制口腔鳞状细胞癌的增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6927-6934. doi: 10.26355/eurrev_201908_18732.
6
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
7
Up-regulation of miR-24-1-5p is involved in the chemoprevention of colorectal cancer by black raspberry anthocyanins.上调 miR-24-1-5p 的表达参与了黑树莓花色苷对结直肠癌的化学预防作用。
Br J Nutr. 2019 Sep 14;122(5):518-526. doi: 10.1017/S0007114518003136. Epub 2018 Dec 17.
8
Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.依维莫司通过 PI3K/AKT/mTOR 信号通路抑制乳腺癌细胞生长。
Mol Med Rep. 2018 May;17(5):7163-7169. doi: 10.3892/mmr.2018.8769. Epub 2018 Mar 16.
9
LINC01088 inhibits tumorigenesis of ovarian epithelial cells by targeting miR-24-1-5p.LINC01088 通过靶向 miR-24-1-5p 抑制卵巢上皮细胞的肿瘤发生。
Sci Rep. 2018 Feb 13;8(1):2876. doi: 10.1038/s41598-018-21164-9.
10
Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma.儿科肿瘤学家在骨肉瘤中提供种系 TP53 检测的意愿。
Cancer. 2018 Mar 15;124(6):1242-1250. doi: 10.1002/cncr.31212. Epub 2018 Jan 3.